Seeking an edge in the competitive market for cancer drugs, an industry giant is taking a bold but risky approach: targeting early stages of the disease
AstraZeneca PLC’s new cancer research chief, José Baselga, wants the company to prioritize early-stage cancers over advanced disease when developing new cancer drugs.
If successful, his unorthodox strategy could reap rewards for both patients—the potential to cure cancer is much greater when it is treated early—and company coffers.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
A top executive at Swiss drug giant Novartis told us the inside story of the $2.1 million price tag for the most expensive drug in the worldThe price tag creates 'sticker shock.' But Novartis says that because the disease is expensive to treat, the drug is worth it in the long run.
Weiterlesen »
Supreme Court blocks bid to sue Merck over Fosamax bone fracturesSupreme Court unanimously blocks, for now, a class-action lawsuit against pharmaceutical giant Merck over 'atypical femoral fractures' caused by osteoporosis drug Fosamax.
Weiterlesen »
Mississippi mayor will pay drug dealers and gang members $10,000 to leave his cityClarksdale Mayor Chuck Espy said he is willing to put hands in own pockets to help reduce crime in city.
Weiterlesen »
O'Rourke suggests penalizing drug manufacturers for the opioid crisisDemocratic presidential candidate Beto O'Rourke will address a host of issues and take questions from voters at a CNN town hall tonight. Follow here for the latest.
Weiterlesen »
At $2 Million, New Novartis Drug Is Priciest EverNovartis said it plans to price its recently approved gene therapy at $2.125 million, making it the world’s most expensive medicine.
Weiterlesen »
Two Clemson football players will miss season after NCAA denies drug test appealClemson players Braden Galloway and Zach Giella will miss the 2019 football season after the NCAA denied appeals of failed drug tests last December.
Weiterlesen »
Lilly selling half-price version of popular insulin drugA half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option.
Weiterlesen »
Trump to Democrats: No deals on infrastructure, drug prices until they drop investigationsDonald Trump told Democratic leaders he wouldn't work with them on shared priorities such as infrastructure unless they abandon 'phony' investigations.
Weiterlesen »
FDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drugThe therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every 11,000 live births.
Weiterlesen »
Big drug distributor pays $22 million to settle US opioid chargesMorris & Dickson, one of the largest U.S. wholesale drug distributors, agreed to pay $22 million in civil penalties to settle U.S. government charges that it failed to report thousands of suspicious orders of the opioids hydrocodone and oxycodone.
Weiterlesen »